Abstract:BACKGROUND:Granulin epithelin precursor (GEP) is reported to function as a growth factor stimulating proliferation and migration, and conferring chemoresistance in many cancer types. However, the expression and functional roles of GEP in colorectal cancer (CRC) remain elusive. The aim of this study was thus to investigate the clinical significance of GEP in CRC and reveal the molecular mechanism of GEP in CRC initiation and progression.METHODS:The mRNA expression of GEP in CRC cell lines were detected by qRT-PCR. The GEP protein expression was validated by immunohistochemistry in tissue microarray (TMA) including 190 CRC patient samples. The clinicopathological correlation analysis were achieved by GEP expression on TMA. Functional roles of GEP were determined by MTT proliferation, monolayer colony formation, cell invasion and migration and in vivo studies through siRNA/shRNA mediated knockdown assays. The cancer signaling pathway identification was acquired by flow cytometry, western blot and luciferase activity assays.RESULTS:The mRNA expression of GEP in CRC was significantly higher than it in normal colon tissues. GEP protein was predominantly localized in the cytoplasm and most of the CRC cases demonstrated abundant GEP protein compared with non-tumorous tissues. GEP overexpression was associated with non-rectal location, advanced AJCC stage, regional lymph node and distant metastasis. By Kaplan-Meier survival analysis, GEP abundance served as a prognostic marker for worse survival in CRC patients. GEP knockdown exhibited anti-cancer effect such as inhibiting cell proliferation, monolayer colony formation, cell invasion and migration in DLD-1 and HCT 116 cells and decelerating xenograft formation in nude mice. siGEP also induced G1 cell cycle arrest and apoptosis. Luciferase activity assays further demonstrated GEP activation was involved in MAPK/ERK signaling pathway.CONCLUSION:In summary, we compressively delineate the oncogenic role of GEP in colorectal tumorigenesis by activating MAPK/ERK signaling pathway. GEP might serve as a useful prognostic biomarker and therapeutic target for CRC.

Tumor Necrosis Factor Receptor 2/AKT and ERK Signaling Pathways Contribute to the Switch from Fibroblasts to CAFs by Progranulin in Microenvironment of Colorectal Cancer.

Characteristics of Primary Cancer Associated Fibroblasts and Normal Fibroblasts and Their Effects on Colorectal Cancer EMT

PGRN Promotes Migration and Invasion of Epithelial Ovarian Cancer Cells Through an Epithelial Mesenchymal Transition Program and the Activation of Cancer Associated Fibroblasts.

Growth Factor Progranulin Promotes Tumorigenesis of Cervical Cancer Via PI3K/Akt/mTOR Signaling Pathway

Colorectal carcinoma-derived fibroblasts modulate natural killer cell phenotype and antitumor cytotoxicity

Progranulin promotes melanoma progression by inhibiting natural killer cell recruitment to the tumor microenvironment.

Progranulin: A promising biomarker and therapeutic target for fibrotic diseases

Interleukin-6-stimulated Progranulin Expression Contributes to the Malignancy of Hepatocellular Carcinoma Cells by Activating Mtor Signaling.

PGRN exacerbates the progression of non-small cell lung cancer via PI3K/AKT/Bcl-2 antiapoptotic signaling

GPR176 Promotes Cancer Progression by Interacting with G Protein GNAS to Restrain Cell Mitophagy in Colorectal Cancer

What Mediates Fibrosis in the Tumor Microenvironment of Clear Renal Cell Carcinoma

Granulin Epithelin Precursor Promotes Colorectal Carcinogenesis by Activating MARK/ERK Pathway

The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts

Cancer-Associated Fibroblasts Promote the Upregulation of PD-L1 Expression Through Akt Phosphorylation in Colorectal Cancer

Interaction with Colon Cancer Cells Hyperactivates TGF-β Signaling in Cancer-Associated Fibroblasts

Progranulin in Regulation Mechanism of Glycolipid Metabolism and Renal Disease

The role of PKM2 nuclear translocation in the constant activation of the NF-B signaling pathway in cancer-associated fibroblasts

FGF-1/-3/FGFR4 Signaling in Cancer-Associated Fibroblasts Promotes Tumor Progression in Colon Cancer Through Erk and MMP-7.

Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion

Intracellular AGR2 transduces PGE2 stimuli to promote epithelial–mesenchymal transition and metastasis of colorectal cancer

Progranulin Promotes Osteogenic Differentiation Of Human Periodontal Ligament Stem Cells Via Tumor Necrosis Factor Receptors To Inhibit Tnf-Alpha Sensitized Nf-Kb And Activate Erk/Jnk Signaling